TrialInternational journal of clinical pharmacology and therapeutics2019

Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects
.

Koutaro Yokote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.